Jérôme Estaquier
Chercheur universitaire
Axe Maladies infectieuses et immunitaires
Dernières nouvelles
Voir toutPublications
Voir tout-
article Clain JA, Picard M, Rabezanahary H, André S, Boutrais S, Goma Matsetse E, Dewatines J, Dueymes Q, Thiboutot E, Racine G, Soundaramourty C, Mammano F, Corbeau P, Zghidi-Abouzid O, Estaquier J
Immune Alterations and Viral Reservoir Atlas in SIV-Infected Chinese Rhesus Macaques
Infect Dis Rep 17 (1), 2025.
-
article Gimenez S, Hamrouni E, André S, Picard M, Soundaramourty C, Lozano C, Vincent T, Tran TA, Kundura L, Estaquier J, Corbeau P
Monocytic reactive oxygen species-induced T-cell apoptosis impairs cellular immune response to SARS-CoV-2 mRNA vaccine
J Allergy Clin Immunol 155 (5), 2025.
-
article Yero A, Shi T, Clain JA, Zghidi-Abouzid O, Racine G, Costiniuk CT, Routy JP, Estaquier J, Jenabian MA
Double-Negative T-Cells during Acute Human Immunodeficiency Virus and Simian Immunodeficiency Virus Infections and Following Early Antiretroviral Therapy Initiation
Viruses 16 (10), 2024.
Projets
- Therapeutic approach to preserve Tfh cells and improve B cell immunity in simian immunodeficiency virus infected rhesus macaques, du 2021-04-01 au 2026-03-31
- National Primate Center for Pandemic Preparedness (NPCPP), du 2024-03-01 au 2028-03-31
- Pre-clinical tools and services for deciphering the repertoires of B and T cells elicited by the immune response in non-human primates (NHP), du 2025-04-08 au 2027-06-30
- Canadian HIV Cure Enterprise 3.0: Targeting tissue HIV reservoirs, du 2025-01-01 au 2029-12-31
- Metabolism of transcriptionally active cells associated with viral reactivation in lymphoid tissues. An approach to cure AIDS, du 2025-02-01 au 2026-01-31
- Deciphering the genomic and immunological factors contributing to asymptomatic Leishmania infantum infections in humans, du 2025-04-01 au 2026-03-31
- Chaire de recherche du Canada en physiopathologie de la mort cellulaire dans les interactions hôtes-pathogènes, du 2018-04-01 au 2025-03-31
- Canadian HIV Cure Enterprise 2.0: Targeting the interplay between myeloid cells and C04+ T-cells for HIV cure, du 2019-04-01 au 2025-03-31
- Manufacturing of antigens and adjuvants for development of vaccines (MAAV), du 2021-07-01 au 2024-03-31
- Prevention of the immunopathology induced by SARS-CoV-2, du 2021-06-01 au 2025-03-31
- Contribution VRRCI - 32e Congrès canadien de recherche sur le VIH/sida (ACRV 2023), du 2023-03-01 au 2024-04-30